Table 2.
Cell Line | ID | Tissue | A locus | B Locus | Cw Locus |
BT-549 | 41292-D | Breast CA | N.R. | 151701, 5501 | 030301, 07a |
HS 578T | 41293-D | Breast CA | 03a, 24a | 35a, 40a | 030401, 04a |
MCF7 | 41294-D | Breast CA | 020101 | 18a, 44a | 05a |
MDA-MB-231 | 41296-D | Breast CA | 0201, 0217 | 4002, 4101 | 020202, 17a |
MDA-MB435 | 41297-D | Breast CA | 110101, 240201 | 15a, 35a | 030301, 04a |
T47D | 41298-D | Breast CA | 3301 | 1402 | 0802 |
SF-268 | 41286-D | CNS CA | 010101, 3201 | 0801, 4002 | 020202, 07a |
SF-295 | 41287-D | CNS CA | 010101, 2601 | 070201, 5501 | 03a, 07a |
SF-539 | 41288-D | CNS CA | 020101 | 08a, 35a | 04a, 07a |
SNB-19 | 41289-D | CNS CA | 020101 | 18a | 05a |
SNB-75 | 41290-D | CNS CA | 020101, 110101 | 35a, 39a | 04a, 120301 |
U251 | 41291-D | CNS CA | 020101 | 18a | 05a |
COLO 205 | 41299-D | Colon CA | 01a, 02a | 07a, 08a | 070201, 07a |
HCC-2998 | 41300-D | Colon CA | 02a, 24a | 3701, 400601 | 04a, 0602 |
HCT-116 | 41301-D | Colon CA | 01a, 02a | 18a, 4501 | 05a, 07a |
HCT-15 | 41302-D | Colon CA | 02a, 24a | 08new, 350101 | 04a, 07a |
HT29 | 41303-D | Colon CA | 01a, 24a | 35a, 440301 | 04a |
KM12 | 41304-D | Colon CA | 02new | 70201 | 70201 |
SW-620 | 41305-D | Colon CA | 02a, 24a | 07a, 15a | 070201, 07a |
MOLT 4 | 41281-D | Leukemia, ALL | 010101, 2501 | 18a, 570101 | 0602, 120301 |
CCRF-CEM | 41282-D | Leukemia, ALL | N.R. | 08a, 40a | 030401, 07a |
HL-60 | 41284-D | Leukemia, APL | 10101 | 570101 | 0602 |
K-562 | 41280-D | Leukemia, CML | 110101, 310102 | 18a, 40a | 03a, N.R. |
SR | 41285-D | Leukemia, LCIL | 02a, 03a | 3701, 3901 | 0602, 120301 |
LOX IMVI | 41315-D | Melanoma | 110101, 2902 | 070201, 440301 | 070201, 1601 |
M 14 | 41316-D | Melanoma | 110101, 240201 | 15a, 35a | 030301, 04a |
SK-MEL-2 | 41317-D | Melanoma | 03a, 26a | 35a, 38a | 04a, 120301 |
SK-MEL-5 | 41319-D | Melanoma | 020101, 110101 | 07a, 40a | 030401, 070201 |
SK-MEL-28 | 41318-D | Melanoma | 110101 | 4001 | 030401 |
UACC-62 | 41321-D | Melanoma | 02a, 32a | 39a, 44a | 05a, 12a |
UACC-257 | 41320-D | Melanoma | 020101 | 18a, 44a | 05a, 07a |
RPMI-8226 | 41283-D | MM | 3001, 6802 | 1503, 1510 | 020204, 030402 |
A549/ATCC | 41306-D | NSCLC | 2501, 3001 | 18a, 440301 | 120301, 1601 |
EKVX | 41307-D | NSCLC | 010101 | 3701 | 0602 |
HOP-62 | 41308-D | NSCLC | 030101 | 07a, 44a | 05a, 070201 |
HOP-92 | 41309-D | NSCLC | 03a, 24a | 27a, 470101 | 01a, 06a |
NCI-H23 | 41312-D | NSCLC | 8001 | 5001 | 0602 |
NCI-H226 | 41311-D | NSCLC | 010101, 240201 | 07a, 39a | 070201, 120301 |
NCI-H322M | 41310-D | NSCLC | 2902 | 440301 | 1601 |
NCI-H460 | 41313-D | NSCLC | 24a, 68a | 35a, 51a | 03a, 15a |
NCI-H522 | 41314-D | NSCLC | 020101 | 44a, 5501 | 030301, 05a |
IGROV1 | 41322-D | Ovarian CA | 240201, 3301 | 4901 | 07a |
OVCAR-3 | 41323-D | Ovarian CA | 020101, 2902 | 070201, 5801 | 070201, 07a |
OVCAR-4 | 41324-D | Ovarian CA | 010101, 3201 | 0801, 4002 | 07a, 15a |
OVCAR-5 | 41325-D | Ovarian CA | 01a, 02a | 08a, 44a | 05a, 07a |
OVCAR-8 | 41326-D | Ovarian CA | 010101, 2501 | 570101 | 0602 |
NCI/ADR-RES | 41295-D | Ovarian CA | 010101, 2501 | 570101 | 0602 |
SK-OV-3 | 41327-D | Ovarian CA | 03a, 68a | 18a, 35a | 04a, 05a |
DU-145 | 41328-D | Prostate CA | 030101, 3303 | 5001, 570101 | 0602 |
PC-3 | 41329-D | Prostate CA | 010101, 240201 | 1302, 5501 | 01a, 06a |
786-O | 41330-D | Renal CA | 030101 | 07a, 44a | 05a, 070201 |
A498 | 41331-D | Renal CA | 020101 | 0801 | 07a |
ACHN | 41332-D | Renal CA | 2601 | 4901 | 07a |
CAKI-1 | 41333-D | Renal CA | 2301, 240201 | 3502, 440301 | 04a, 04new |
SN12C | 41334-D | Renal CA | 03, 24new | 07a, 44a | 05a, 070201 |
TK-10 | 41335-D | Renal CA | 3301 | 1402 | 0802 |
UO-31 | 41336-D | Renal CA | 010101, 030101 | 07a, 14a | 07a, 08a |
RXF-393 | 41337-D | Renal CA | 02a, 24a | 1401, 44a | 05a, 0802 |
Sequence-based typing for the HLA class I loci are reported with the highest degree of resolution. Non-resolved ambiguities are reported as two digit denominations with a superscript a as previously described 43. HLA typings divergent from those originally described in the ATCC database are reported in red. ID# refers to the HLA laboratory reference number. New alleles are indicated by the suffix new following the allele. N.R. – Ambiguity not resolved at the lower level of resolution.